Facebook
Twitter
LinkedIn
Forward
2022 Multidisciplinary Head and Neck Cancers Symposium onDemand
The 2022 Multidisciplinary Head and Neck Cancers Symposium features interactive and case-based educational sessions that cover new multidisciplinary therapies, imaging, immunotherapy, treatment guidelines, supportive care and under disparities in head and neck cancer. A major focus is placed on the multidisciplinary nature of disease management and the incorporation of all treatment modalities to achieve best outcomes. Oral abstract and poster sessions will highlight cutting-edge science and evidence-based practice. Registrants will be able to examine multidisciplinary approaches for treating head and neck cancer, as well as novel therapies that show promise in improving outcomes.
Target Audience
This meeting is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, nurses, diagnostic radiologists, pathologists, radiation therapists, radiation dosimetrists, speech language pathologists/scientists, dentists, oral surgeons, swallowing and speech therapists, audiologists, physical therapists, scientists, immunologist and rehabilitation specialists.
Learning Objectives
Upon completion of this activity, registrants should be able to do the following:
- Explain the importance of multidisciplinary care in head and neck cancer (HNC) and how to best apply it for optimal outcomes.
- Describe key advances in systemic therapy, including targeted therapy and immunotherapy in HNC.
- Discuss recent advances in minimally invasive surgery in HNC and when to apply it in treating early and locally advanced disease.
- Illustrate how we can improve disparities in head and neck cancer care.
- Determine the importance of interventions in survivorship clinics for long term side effects.
- Describe key advances in radiation therapy delivery, targeting and differences between various modalities, including novel treatment approaches such as proton and FLASH radiotherapy.
- Discuss complex cases in HNC and how to best utilize current knowledge for decision-making.
- Manage toxicities related to the management of head and neck cancer.
- Summarize key recent advances in HNC biology.
- Summarize key recent advances in HNC imaging.
- Discuss and implement standard treatment guidelines for various subtypes of HNCs.
PROGRAM INSTRUCTIONS:
Registration:
Click on the Register tab in the course navigation. Scroll down to add the On Demand Course to your cart. All sessions listed are included with your purchase.
Navigation:
To begin:
- Click on the Take Course tab in the course navigation to see the list of included sessions.
- Click on the title of the session you would like to view.
- Once in the session, review the overview, objectives, and faculty details before clicking Take Course to begin viewing the content.
- Use the left Course Progress bar to navigate the session or the green buttons in the course navigation bar at the bottom.
- You may view the sessions in any order and as many or as few as you wish to receive credit(s).
Once you have completed each session, you can return to the list of sessions available by clicking on Return to 2022 Multidisciplinary Head and Neck Cancers Symposium onDemand as seen in the example below.
Repeat the above steps to complete as many sessions as you wish to view. You may return later to complete or review any of the sessions.
To re-enter the On Demand course, you will find your 2022 Multidisciplinary Head and Neck Cancers Symposium onDemand in your Completed Activities tab even if you have sessions that have not been viewed available.
Go to the Take Course tab to re-access. Sessions that have been viewed/completed will have a checked circle and unviewed sessions will say Enrolled. You can view sessions as many times as you would like.
Certificates/Credits
You may view and claim credit for some or all of the virtual sessions. Each time you complete the viewing and evaluation of a session, your CME certificate for the course will update with the new credit hours awarded.
Name | Employment | Compensation/Renumeration/Funding | Ownership/Investment Interests | Leadership Positions |
|---|---|---|---|---|
| Julie Bauman | University of Arizona: Professor of Medicine: Employee | None | None | None |
| Liza Blumenfeld | UC San Diego, Moores Cancer Center: Professor: Employee | None | None | None |
| Margaret Brandwein-Weber | Mount Sinai School of Medicine: Professor and Chief of Pathology | None | None | None |
| David Burkett | The Burkett Law Firm: Owner, President and Lead attorney | None | Abbvie: Stock Eli Lilly: Stock | None |
| Elizabeth Cash | University of Louisville: Employee | None | None | None |
| Anne Chang | Stanford University: Employee | Merck: clinical investigator and advisory panel Regeneron: clinical investigator and advisory board: | None | None |
| Bhisham Chera | University of North Carolina Hospitals: Associate Professor: Employee | RO-HAC: Consultant | Naveris: Patent/License Fees/Copyright: Stock | ACR: Editor Head and Neck: Senior Editor Naveris: Scientific Advisory Board: Scientific Advisory Board Practical Radiation Oncology: Senior Editor: Senior Editor |
| Christine Chung | Moffitt Cancer Center: Senior Member: Employee | Exelixis: Honoraria Merck: Honoraria Sanofi: Honoraria | None | None |
| Alexander Dimitrios Colevas | Stanford university: Professor: Employee | Abbvie: Research Grants AdPNP: Research Grants Aravive: Advisory Board ATARA Biotherapeutics: Research Grants BeiGene, Ltd: Consultant BioNTech: Research Grants Clarion: Interview Clearview HCP (Clearview Oncology): Expert Interview CUE Biopharma: Research Grants Cue Biopharma, Inc.: Research Grants Cullinan: Research Grants ECTCN: Research Grants Exelixis: Research Grants Forty Seven, Inc./Gilead: Research Grants Gilead: Advisory Board Gilead: Research Grants Innate Pharma: Research Grants NCI: Research Grants NRG Oncology: Research Grants Replimune: Research Grants Tessa Therapeutics: Research Grants | None | Assn n cal oncologists: Board member Nccn: Panel member: Formulate guidelines |
| Jonas de Souza | HCA Healthcare: VP Strategy: Employee Humana Inc: Director, Strategy: Employee: Relationship ended 06/11/2021 | None | HCA Healthcare: Stock Options Humana Inc: Stock | Patient Access Network: Board of Directors: Director |
| Neal Dunlap | University of Louisville/James Graham Brown Cancer Center: Employee | None | None | None |
| Umamaheswar Duvvuri | University of Pittsburgh, School of Medicine: Professor: Employee | Activ Surgical: Consultant | None | Activ Surgical: Advisory Board: Consultant |
| Joel Epstein | Cedars Sinai: Consulting dentist: Independent Contractor City of Hope: Consulting dentist: Independent Contractor | Cedars Sinai: Consultant City of Hope: Research Grants | None | Multinational Assocfor Supportive Care in Cancer: Member: Board Member: Relationship ended 12/31/2019 |
| Renata Ferrarotto | MD Anderson Cancer Center: Associate Professor: Employee | Ayala Pharmaceutical: Advisory Board: Research Grants EMD Serono: Research Grants Merck: Advisory Board Nanobiotix: Research Grants Pfizer: Research Grants Regeneron-Sanofi: Advisory Board | None | None |
| Robert Ferris | UPMC Hillman Cancer Center: Employee University of Pittsburgh School of Medicine: Director | Achilles Therapeutics: Advisory Board Aduro Biotech, Inc: Consultant Astra-Zeneca/MedImmune: Research Funding & Clinical Trial Bicara Therapeutics, Inc: Consultant Bristol-Myers Squibb: Advisory Board: Clinical Trial & Research Funding Brooklyn Immunotherapeutics LLC: Consultant Everest Clinical Research Corporation: Consultant F. Hoffmann-La Roche Ltd: Consultant Genocea Biosciences, Inc: Consultant Hookipa Biotech GmbH: Advisory Board Instil Bio, Inc: Advisory Board Kowa Research Institute, Inc: Consultant Lifescience Dynamics Limited: Advisory Board MacroGenics, Inc.: Advisory Board Merck: Advisory Board: Clinical Trial Mirati Therapeutics, Inc: Consultant Nanobiotix: Consultant Novasenta: Consultant: Research Grants Numab Therapeutics AG: Advisory Board OncoCyte Corporation: Advisory Board Pfizer: Advisory Board PPD Development, L.P.: Consultant Rakuten Medical, Inc: Advisory Board Sanofi: Consultant Seagen, Inc: Advisory Board Tesaro: Research Grants Vir Biotechnology, Inc: Advisory Board Zymeworks, Inc.: Consultant | Novasenta: Stock | None |
| Jessica Geiger | Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic | None | None | None |
| Maura Gillison | UT MD Anderson Cancer Center: Professor: Employee | Bayer Healthcare: Consultant Bicara Therapeutics: Consultant BioNTech AG: Research Grants Bristol-Myers Squibb: Consultant: Research Grants Cullinan: Research Grants Debiopharm: Consultant Eisai Inc.: Consultant EMD Serono: Consultant Genenetch: Research Grants Genocea Bioscience: Research Grants Gilead: Research Grants Ipsen Biopharmaceuticals Inc.: Consultant Istari Oncology Inc.: Consultant Kura Oncology Inc.: Research Grants LLX Solutions, LLC: Consultant Merck & Co. Inc.: Consultant Nektar: Consultant Roche Laboratories, Inc.: Consultant Seagen: Consultant Sensei Biotherapeutics Inc.: Consultant Shattucks Lab Inc.: Consultant | None | Memorial Slan Kettering Cancer Center: Consultant: Committee Member |
| Neil Hayes | The University of Tennessee Health Science Center: Employee | Merck: Advisory Board | GeneCentric Therapeutics: Founder, license fees, consultant | None |
| Zain Husain | Sunnybrook Health Sciences Centre: Physician/Associate Professor: Staff Physician | None | None | NIH Head and neck PULA task force: Member |
| Katherine Hutcheson | University of Houston: Adjunct Professor: Employee University of Texas MD Anderson Cancer Center: Professor: Employee | Atos Medical: In-kind Donations: Research Grants MD Anderson Institutional Research Grant Program: Research Grants National Institutes of Health: Research Grants Patient Centered Outcomes Research Institute: Research Grants THRIVE/HESI Foundation: Research Grants | None | Head and Neck Cancer Alliance: Board Member |
| Jonathan Irish | Department of Otolaryngology - Head & Neck Surgery, University Health Network, University of Toronto: Professor Ontario Health-Cancer Care Ontario: Vice President of Clinical for Cancer Programs | None | None | None |
| Faye Johnson | Department of Thoracic Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center: Professor | Takeda: Research Grants Trovagene: Research Grants | None | None |
| Kiran Kakarala | Department of Otolaryngology, University of Kansas Medical Center: Associate Professor | None | None | American Head and Neck Society: Co-Chair: Co-Chair of Quality Committee American Head and Neck Society: Vice-Chair: Vice Chair of Salivary Section |
| Sana Karam | University of Colorado, Anschutz Medical Campus: Associate Professor and Vice Chair of Translational Research: Employee | AstraZeneca: Research Grants Genentech: Research Grants Roche: Research Grants | None | None |
| Saad Khan | UT Southwestern: Employee | None | None | None |
| Shlomo Koyfman | Cleveland Clinic: Associate Professor of Medicine: Employee | BristolMyersSquibb: Research Grants Castle Biosciences: Advisory board (unpaid) Merck: Advisory Board: Research Grants Regeneron: Advisory Board UpToDate: Honoraria | None | None |
| Stephen Lai | Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center: Employee | Cardinal Health: Consultant | None | None |
| Quynh-Thu Le | Stanford: Professor: Employee | Coherus: Consultant Merck: Travel Expenses Nanobiotix: Consultant NIH: Research Grants Pfizer: Consultant Roche: Consultant | Aldea: Stock | American Radium Society: President elect: Relationship ended Head and Neck Cancer International Group (HNCIG): Chair RTOG NRG Cooperative group: Head and Neck Committee Chair: Chair of head and neck committee- design clinical trial |
| Nancy Lee | Memorial Sloan-Kettering Cancer Center: Vice Chairman: Employee | Astra Zeneca: Research Grants Elsie: Advisory Board Merck: Advisory Board: Research Grants Merck Serono: Advisory Board Pfizer: Advisory Board: Research Grants; Roche: Advisory Board | None | None |
| Kelly Malloy | University of Michigan: Associate Professor: Employee | Up To Date: Royalty for authored content | None | None |
| Susan McCammon | University of Alabama at Birmingham: Professor | None | None | None |
| Loren Mell | UCSD: Professor: Employee | Astra-Zeneca: Research Grants Merck: Research Grants | None | None |
| Charles Moore | Indiana University: Professor, Vice Chair of Academic Affairs and Medical Director of the Health Joe and Shelly Schwartz Cancer Center | None | None | None |
| Michael Moore | IU HEALTH: Medical Director Schwartz Cancer Center: Employee | Cancer support community: Advisory Board Gazak and Brown: Honoraria Intuitive Surgical Inc: Travel Expenses PK Law: Honoraria Rakuten medical: Advisory Board | None | HEAD AND NECK CANCER ALLIANCE: PRESIDENT OF THE BOARD: I Oversee the Board and help guide the strategic plan for the organization. |
| Cherie-Ann Nathan | LSU Health: Professor and Chair: Employee | None | None | None |
| Marci Nilsen | School of Nusring and School of Medicine, University of Pittsburgh: Assistant Professor | None | None | None |
| Devin Okay | Mount Sinai Hospital: Employee | None | None | None |
| Urjeet Patel | Northwestern Memorial Hospital: Attending Physician | None | None | None |
| Andy Pluemer | None | None | None | |
| Eben Rosenthal | Department of Otolaryngology—Head and Neck Surgery, Vanderbilt University Medical Center: Guy Maness Profesor and Chair | NIH: Research Grants Vergent: Consultant | None | None |
| Gloria Rubio | UC San Diego, Moores Cancer Center: Employee | None | None | None |
| Nabil Saba | Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University: Employee | None | None | None |
| Assuntina Sacco | University of California, San Diego Health: Associate Professor of Internal Medicine: Employee | Bicara Therapeutics: Advisory Board FirstThought: Consultant Merck: Research Grants Verimed: Consultant | None | American Radium Society: Head and Neck Appropriateness Use Criteria Committee: Expert: Relationship ended 07/01/2021 NCI PULA Task Force: NCI PULA Task Force: Special Expert |
| Cecelia Schmalbach | Temple Health: Employee | None | None | None |
| Farzan Siddiqui | Henry Ford Health System: Senior Staff Physician: Employee | American College of Radiology: Honoraria Varian Medial Systems Inc: Honoraria: Speaker's Bureau: Travel Expenses: Research Grants: Travel Expenses Varian Noona: Advisory Board | None | American Radium Society: Member; Department of Radiation Oncology, Henry Ford Hosp: Vice-Chairman Operations: Serve as liaison between Health System leadership and department Henry Ford Medical Group Board of Governors: Member HFHS Bylaws and Governance Committee: Committee Chair |
| Jennifer Sipos | Arthur G. James Comprehensive Cancer Center: Physician Ohio State University: Physician | None | None | None |
| Heath Skinner | MD Anderson Cancer Center: Assistant Professor: Employee: Relationship ended 08/31/2018 MD Anderson Cancer Center: Associate Professor: Employee: Relationship ended 09/10/2018 UPMC Hillman Cancer Center: Associate Professor: Employee | NIDCR: Research Grants NIH: Research Grants | None | None |
| Sharon Spencer | University of Alabama at Birmingham: Radiation oncologist | None | None | None |
| Maie St. John | UCLA Geffen School of Medicine: Professor and Chair Head and Neck Surgery: Employee | None | None | None |
| Heather Starmer | Stanford University: Clinical Associate Professor: Employee | None | None | Am Board of Swallowing and Swallowing disorders: Board member: Co-chair of continuing education committee American Head and Neck Society: Co-chair: service co-chair for head and neck cancer survivorship American Speech Language Hearing Association: Topic chair: Topic chair for annual convention Dysphagia Research Society: board member: Service on committee for membership |
| Paul Swiecicki | Department of Internal Medicine, Division of Medical Oncology, University of Michigan: Assistant Professor of Hematology/Oncology, Co-Director of Multitumor Experimental Therapeutics/Phase 1 Program | None | None | None |
| Ravindra Uppaluri | Department of Surgery/Otolaryngology, Brigham & Women's Hospital: Division Cheif Head and Neck Surgery, Dana-Farber Cancer Institute: Director | Merck Inc: Advisory Board | None | None |
| MarkVarvares | Massachusetts General Hospital: Employee | None | None | None |
| Head and Neck Cancer Alliance: Patient Advocate | None | None | None | |
| Sue Yom | University of California: Employee | ASTRO: Honoraria BioMimetix: Research Grants Bristol-Myers Squibb: Research Grants Elsevier: Honoraria Genentech: Research Grants Merck: Research Grants Springer: Book chapter royalty UpToDate: Book chapter royalty | None | American Society for Radiation Oncology: Deputy Editor NRG Oncology: Chair |
| Mark Zafereo | Head and Neck Surgery, The University of Texas MD Anderson Cancer Center: Professor | Eli Lilly: Research Grants; Merck: Research Grants | None | American Academcy of Otololaryngology-Head & Neck Surgery: Board of Directors; International Thyroid Oncology Group: Board of Directors |
| Dan Zandberg | UPMC Hillman Cancer Center, University of Pittsburgh: Employee | None | None | None |
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 17.00 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 17.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 17.00 Certificate of AttendanceThis activity was designated for 17.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
$275 for all member types.
Policies:
No refunds, extensions, or substitutions will be made for those registrants. Including those who for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.”
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.